Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

FDA clears ECG feature for ‘prescription-only’ smartwatch
5-year data show no link between paclitaxel dose and mortality with Medtronic DCB
American Society of Echocardiography unveils new guidelines for comprehensive TTE
Abbott gains FDA approval for TactiCath AFib ablation catheter
Alert dogs for T1D show promise in detecting owners’ blood sugar changes
Post-TAVR conduction abnormalities tied to worse outcomes
Plaque characteristics boost predictive power of CTA risk scoring
Companies raised prices for valsartan following recalls
Culture of interventional cardiology drives women away
FDA to evaluate potential risks of paclitaxel-coated devices for PAD